These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20427856)

  • 41. Neutron dosimetry in organs of an adult human phantom using linacs with multileaf collimator in radiotherapy treatments.
    Martinez-Ovalle SA; Barquero R; Gomez-Ros JM; Lallena AM
    Med Phys; 2012 May; 39(5):2854-66. PubMed ID: 22559658
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Out-of-field doses for scanning proton radiotherapy of shallowly located paediatric tumours-a comparison of range shifter and 3D printed compensator.
    Wochnik A; Stolarczyk L; Ambrožová I; Davídková M; De Saint-Hubert M; Domański S; Domingo C; Knežević Ž; Kopeć R; Kuć M; Majer M; Mojżeszek N; Mares V; Martínez-Rovira I; Caballero-Pacheco MÁ; Pyszka E; Swakoń J; Trinkl S; Tisi M; Harrison R; Olko P
    Phys Med Biol; 2021 Jan; 66(3):035012. PubMed ID: 33202399
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monte Carlo study shows no significant difference in second cancer risk between 6- and 18-MV intensity-modulated radiation therapy.
    Kry SF; Salehpour M; Titt U; White RA; Stovall M; Followill D
    Radiother Oncol; 2009 Apr; 91(1):132-7. PubMed ID: 19147246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measured Neutron Spectra and Dose Equivalents From a Mevion Single-Room, Passively Scattered Proton System Used for Craniospinal Irradiation.
    Howell RM; Burgett EA; Isaacs D; Price Hedrick SG; Reilly MP; Rankine LJ; Grantham KK; Perkins S; Klein EE
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):249-257. PubMed ID: 27084645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomas.
    Fuji H; Schneider U; Ishida Y; Konno M; Yamashita H; Kase Y; Murayama S; Onoe T; Ogawa H; Harada H; Asakura H; Nishimura T
    Radiat Oncol; 2013 Nov; 8():255. PubMed ID: 24180282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of IMRT and proton radiotherapy on secondary cancer incidence.
    Schneider U; Lomax A; Pemler P; Besserer J; Ross D; Lombriser N; Kaser-Hotz B
    Strahlenther Onkol; 2006 Nov; 182(11):647-52. PubMed ID: 17072522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
    Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peripheral photon and neutron doses from prostate cancer external beam irradiation.
    Bezak E; Takam R; Marcu LG
    Radiat Prot Dosimetry; 2015 Dec; 167(4):591-601. PubMed ID: 25564673
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measurement of neutron dose equivalent and its dependence on beam configuration for a passive scattering proton delivery system.
    Wang X; Sahoo N; Zhu RX; Zullo JR; Gillin MT
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1563-70. PubMed ID: 20097484
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Secondary neutron dosimetry for conformal FLASH proton therapy.
    Chen D; Motlagh SAO; Stappen FV; Labarbe R; Bell B; Kim M; Teo BK; Dong L; Zou W; Diffenderfer ES
    Med Phys; 2024 Jul; 51(7):5081-5093. PubMed ID: 38597815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dose distribution of secondary radiation in a water phantom for a proton pencil beam-EURADOS WG9 intercomparison exercise.
    Stolarczyk L; Trinkl S; Romero-Expósito M; Mojżeszek N; Ambrozova I; Domingo C; Davídková M; Farah J; Kłodowska M; Knežević Ž; Liszka M; Majer M; Miljanić S; Ploc O; Schwarz M; Harrison RM; Olko P
    Phys Med Biol; 2018 Apr; 63(8):085017. PubMed ID: 29509148
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
    Mock U; Bogner J; Georg D; Auberger T; Pötter R
    Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of respiratory motion on passively scattered proton therapy versus intensity modulated photon therapy for stage III lung cancer: are proton plans more sensitive to breathing motion?
    Matney J; Park PC; Bluett J; Chen YP; Liu W; Court LE; Liao Z; Li H; Mohan R
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):576-82. PubMed ID: 24074932
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measurements of secondary neutron dose from 15 MV and 18 MV IMRT.
    Howell RM; Ferenci MS; Hertel NE; Fullerton GD; Fox T; Davis LW
    Radiat Prot Dosimetry; 2005; 115(1-4):508-12. PubMed ID: 16381776
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neutron and photon out-of-field doses at cardiac implantable electronic device (CIED) depths.
    Aslian H; Severgnini M; Khaledi N; Ren Kaiser S; Delana A; Vidimari R; de Denaro M; Longo F
    Appl Radiat Isot; 2021 Oct; 176():109895. PubMed ID: 34419874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neutron scattered dose equivalent to a fetus from proton radiotherapy of the mother.
    Mesoloras G; Sandison GA; Stewart RD; Farr JB; Hsi WC
    Med Phys; 2006 Jul; 33(7):2479-90. PubMed ID: 16898451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age.
    Zacharatou Jarlskog C; Paganetti H
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):228-35. PubMed ID: 18571337
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Semi-experimental assessment of neutron equivalent dose and secondary cancer risk for off-field organs in glioma patients undergoing 18-MV radiotherapy.
    Elmtalab S; Abedi I; Alirezaei Z; Choopan Dastjerdi MH; Geraily G; Karimi AH
    PLoS One; 2022; 17(7):e0271028. PubMed ID: 35905102
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
    Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Secondary neutron dose during proton therapy using spot scanning.
    Schneider U; Agosteo S; Pedroni E; Besserer J
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):244-51. PubMed ID: 12007965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.